Primary Sjögren's syndrome 1976-2005 and associated interstitial lung disease: A population-based study of incidence and mortality

BMJ Open

Volumn 3, Issue 11, 2013, Pages

  Nannini, Carlotta ^a,b   Jebakumar, Adlene J ^a   Crowson, Cynthia S ^a   Ryu, Jay H ^a   Matteson, Eric L ^a  

^a Mayo Clinic   (United States)

^b Prato Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FAMILIAL INCIDENCE; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIMARY SJOEGREN SYNDROME; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SJOEGREN SYNDROME; STANDARDIZED MORTALITY RATIO;

EID: 84890392141     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-003569     Document Type: Article

References (31)

1. Manthorpe R, Asmussen K, Oxholm P. Primary Sjögren's syndrome: diagnostic criteria, clinical features, and disease activity. VIth International Symposium on Sjögren's syndrome: Avon Connecticut, USA. J Rheumatol 1997;24(Suppl 50):8-11.
2. Binard A, Devauchelle-Pensec V, Fautrel B, et al. Epidemiology of Sjögren's syndrome: where are we? Clin Exp Rheumatol 2007;25:1-4.
3. Pillemer SR, Matteson EL, Jacobsson LTH, et al. Incidence of physician-diagnosed primary Sjögren's syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 2001;76:593-9.
4. Drosos AA, Andonopoulos AP, Costopoulos JS, et al. Prevalence of primary Sjögren's syndrome in an elderly population. Br J Rheumatol 1988;27:123-7.
5. Hochberg MC, Schein OD, Munoz B, et al. The prevalence of dry eye, dry mouth, autoimmunity and primary Sjögren' s syndrome in the general population. Arthritis Rheum 1996;39:S66.
6. Dafni UG, Tzioufas AG, Staikos P, et al. Prevalence of Sjögren's syndrome in a closed rural community. Ann Rheum Dis 1997;56:521-5.
7. Parambil JG, Myers JL, Lindell RM, et al. Interstitial lung disease in primary Sjögren syndrome. Chest 2006;130:1489-95.
8. Parke AL. Pulmonary manifestations of primary Sjögren's syndrome. Rheum Dis Clin North Am 2008;34:907-20.
9. Lin DF, Yan SM, Zhao Y, et al. Clinical and prognostic characteristics of 573 cases of primary Sjögren 's syndrome. Chin Med J (Engl) 2010;123:3252-7.
10. Gardiner P, Ward C, Allison A, et al. Pleuropulmonary abnormalities in primary Sjögren's syndrome. J Rheumatol 1993;20:831-7.
11. Deheinzelin D, Capelozzi VL, Kairalla RA. et al. Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996;154(3 Pt 1):794-9.
12. Ju-Hong S, Hong-Rui L, Weng-Bin X, et al. Pulmonary manifestations in Sjögren's syndrome. Respiration 2009;78:377-86.
13. St Sauver JL, Grossardt BR, Yawn BP, et al. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol 2011;173:1059-68.
14. Melton LJ III. History of the Rochester epidemiology project. Mayo Clin Proc 1996;71:266-74.
15. Vitali C, Bombardieri S, Jonsson R. et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
16. Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 2010; 62:1583-91.
17. Bergstralh EJ, Offord KP, Chu CP, et al. Technical Report Series No. 49. Calculating incidence, prevalence and mortality rates for Olmsted County, Minnesota: an update. Rochester, (MN): Section of Biostatistics, Mayo Clinic, 1992.
18. McCullagh P, Nelder JA. Generalized linear models. New York: Chapman & Hall, 1983.
19. Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695-706.
20. Therneau TM, Offord J. Expected survival based on hazard rates (updated). Technical Report Series No. 63. Rochester, (MN): Mayo Clinic Department of Health Sciences Research, 1999.
21. Alamanos Y, Tsifetaki N, Vulgari PV, et al. Epidemiology of primary Sjögren's syndrome in north-west Greece 1982-2003. Rheumatology 2006;45:187-91.
22. Plesivcnik NM, Rozman B, Hocevar A, et al. Incidence of primary Sjögren's syndrome in Slovenia. Ann Rheum Dis 2004;63:874-6.
23. Skopouli FN, Dafni U, Ioannidis JP, et al. Clinical evaluation morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum 2000;29:296-304.
24. Theander E, Manthorpe R, Jacobsson LT. Mortality and cause of death in primary Sjögren's syndrome: a prospective cohort study. Arthritis Rheum 2004;50:1262-9.
25. Ionnidis JP, Vassiliou VA, Moutsopoulos HM. Long term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002;46:741-7.
26. Ramos Casals M, Brito-Zeron P, Yague J, et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjögren's syndrome. Rheumatology 2005;44:89-94.
27. Brito-Zeron P, Ramos-Casals M, Bova A, et al. Predicting adverse outcomes in primary Sjögren's syndrome: identification of prognostic factors. Rheumatology 2007;46:1359-62.
28. Martens PB, Pillmer SR, Jacobsson LTH, et al. Survivorship in a population based cohort of patients with Sjögren's syndrome 1976-1992. J Rheumatol 1999;26:1296-300.
29. Kruize AA, Hene RJ, van der Heide A, et al. Long term follow up of patients with Sjögren's syndrome. Arthritis Rheum 1996;39:297-303.
30. Shiboski SC, Shiboski CH, Criswell LA, et al. American College of Rheumatology classification criteria for Sjögren syndrome: a data driven, expert consensus approach in the Sjögren International Collaborative Clinical Alliance cohort. Arthritis Care Res 2012;64:475-87.
31. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277-304.